-
摘要: 目的:老年合并主动脉壁内血肿(IMH)的临床分析。方法:选取2013年5月-2018年5月我院收治的所有老年IMH 104例,分为A型主动脉壁内血肿(IMH-A)组和B型主动脉壁内血肿(IMH-B)组。进行5年的随访研究,研究终点为死亡。结果:IMH-A组主动脉瓣关闭不全明显高于IMH-B组。IMH-B组外科手术治疗比例较低(23.8%),主要为主动脉覆膜支架植入术,IMH-A组则以升主动脉及主动脉半弓置换术为主的体外循环手术,两组比较差异有统计学差异。此外两组院内死亡率、全因死亡率相近,两组的中位生存时间分别为(49.0∶55.2)个月,经Log-rank检验无统计学意义(P=0.933)。亚组分析中,内科组、外科组中位生存时间分别为(53.9∶51.7)个月,但经Log-rank检验差异仍无统计学意义(P=0.875)。结论:老年IMH的首选治疗方式仍为内科治疗为主,外科治疗可能改善老年A型壁间血肿的预后。Abstract: Objective:To analyze the elderly patients with intra-aortic hematoma(IMH).Method:The 104 patients with IMH were retrospectively included in this study from May 2013 to May 2018.They were divided into IMH-A group and IMH-B group according to imaging analysis.After the 5 year follow-up study was performed.The study endpoint was clinical death.Result:Aortic valve insufficiency was significantly higher in the IMH-A group than in the IMH-B group.IMH-B group had a lower surgical treatment ratio(23.8%).In terms of surgical treatment,All of the IMH-B group was treated with intracavity aorta and stent implantation.IMH-A group included aortic replacement under cardiopulmonary bypass.All-cause mortality was similar between the two groups.The survival times were(49.0 vs 55.2 months),and no significant difference was found by Log-rank test(P=0.933).In the subgroup analysis,the median survival time of the medical group and the surgical group were(53.9 vs 51.7 months),but the difference was not statistically significant by Log-rank test(P=0.875).Conclusion:The preferred treatment for elderly IMH is still medical treatment,and surgical treatment may improve the prognosis of elderly IMH-A.
-
Key words:
- acute aortic syndrome /
- aortic hematoma /
- elderly /
- medical treatment /
- surgical treatment
-
-
[1] 刘鹏,苏德淳,杨光,等.急性主动脉综合征并发弥漫性血管内凝血的临床研究[J].临床心血管病杂志,2017,33(11):1083-1086.
[2] 刘鹏,刘红阳,黄日红等.重组人凝血因子Ⅶa治疗急性Stanford A型主动脉夹层术后严重出血并发症的临床研究[J].临床心血管病杂志,2019,35(2):145-148.
[3] Evangelista A,Mukherjee D,Mehta RH,et al.Acute intramural hematoma of the aorta:a mystery in evolution[J].Circulation,2005,111(8):1063-1070.
[4] Hiratzka LF,Bakris GL,Beckman JA,et al.2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease [J].Circulation,2010,121(13):e266-369.
[5] 李江,赵建廷,沈利明,等.60岁以上非外伤性主动脉壁内血肿患者临床特点及治疗[J].中华胸心血管外科杂志,2019,35(1):25-28.
[6] Erbel R,Aboyans V,Boileau C,et al.2014 ESC Guidelines on the diagnosis and treatment of aortic diseases [J].Eur Heart J,2014,35(41):2873-2926.
[7] Kitai T,Kaji S,Yamamuro A,et al.Clinical outcomes of medical therapy and timely operation in initially diagnosed Type A aortic intramural hematoma:a 20-year experience[J].Circulation,2009,120:S292-298
[8] Sandhu HK,Tanaka A,Charlton-Ouw KM,et al.Outcomes and management of type A intramural hematoma[J].Ann Cardiothorac Surg,2016,5(4):317-327.
[9] Rozado J,Martin M,Pascual I,et al.Comparing American,European and Asian practice guidelines for aortic diseases[J].J Thorac Dis,2017,9(Suppl 6):S551-S560.
[10] JCS Joint Working Group.Guidelines for diagnosis and treatment of aortic aneurysm and aortic dissection (JCS 2011):digest version[J].Circ J,2013,77(3):789-828.
[11] 中国医师协会心血管外科分会大血管外科专业委员会.主动脉夹层诊断与治疗规范中国专家共识[J].中华胸心血管外科杂志,2017,33(11):641-654.
[12] Zhou X,Krishnan A,Hsu J,et al.Delayed surgical management of type A intramural hematoma is not associated with worse outcomes than emergent operation[J].Heart Surg Forum,2019,22(2):E103-E106.
[13] Choi YJ,Son JW,Lee SH,et al.Treatment patterns and their outcomes of acute aortic intramural hematoma in real world:multicenter registry for aortic intramural hematoma[J].BMC Cardiovasc Disord,2014,14:103.
[14] 戴仕林,吴伟,王贤灿,等.78例累及主动脉弓的主动脉疾病患者弓部处理方式及早期随访结果[J].临床心血管病杂志,2017,33(7):678-682.
-
计量
- 文章访问数: 317
- PDF下载数: 211
- 施引文献: 0
下载: